Literature DB >> 789084

Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.

S Roth, K Naber, M Scheer, G Gruenwaldt, H Lange.   

Abstract

Serum concentration, biological half-life, distribution space and serum clearance of sisomicin, a new aminoglycoside antibiotic, have been studied in twenty-three patients in comparison with the pharmacokinetics of 125I-labelled iothalamate, a compound only filtered by the kidney. 10 patients had normal or borderline abnormal serum creatinine (less than 1,5 mg/100 ml), 8 had various degrees of renal insufficiency (serum creatinine 1.7-9.6 mg/100 ml) and 6 were being treated by intermittent haemodialysis. After intravenous injection of sisomicin 1 mg/kg body weight in patients with normal or borderline renal function its half-life was 3.5 h, very similar to that of iothalamate, 3.2 h. The mean distribution space was 20.1% per cent of body weight; iothalamate, 23.7%. In patients with renal insufficiency there was a positive correlation between serum creatinine level and the half-life of sisomicin, and an even stronger correlation between the clearances of iothalamate and sisomicin. In patients dependent on haemodialysis, the mean serum half-life between dialysis was 40 h, compared to approximately 100 hours for iothalamate, which implies additional extrarenal clearance or tubular secretion of sisomicin. The results of pharmacokinetic studies indicated that a regime of sisomicin 1 mg/kg every 8 to 12 hours in patients with normal renal function would result in serum and urine levels sufficiently high to treat most urinary tract infections. In patients with impaired renal function the dosage interval should be increased according to the serum creatinine level, and in patients dependent on haemodialysis one standard dose at the end of each dialysis period should suffice. 9 patients with a chronic urinary tract infection severely complicated by an underlying disease were treated according to this dosage regimen with a satisfactory bacteriological and clinical result. No adverse reactions or signs of accumulation were observed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789084     DOI: 10.1007/bf00565626

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  [Binding of sisomicin and gentamicin to serum proteins (author's transl)].

Authors:  H Rosenkranz; M Scheer; W Scholtan
Journal:  Arzneimittelforschung       Date:  1976

2.  Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.

Authors:  S R Westenfelder; K G Naber; P O Madsen
Journal:  Infection       Date:  1973       Impact factor: 3.553

3.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

4.  Renal hemodynamics and limitations of creatinine clearance in determining filtration rate in glomerular disease.

Authors:  B Hood; P O Attman; J Ahlmén; R Jagenburg
Journal:  Scand J Urol Nephrol       Date:  1971

5.  Pharmacokinetics of gentamicin: distribution and plasma and renal clearance.

Authors:  A M Gyselynck; A Forrey; R Cutler
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers.

Authors:  J Klastersky; A Henri; C Hensgens; L Vandenborre; D Daneau
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

7.  Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.

Authors:  J A Waitz; E L Moss; E M Oden; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1970-11       Impact factor: 2.649

8.  The measurement of glomerular filtration rate in man with sodium iothalamate 131-I (Conray).

Authors:  E M Sigman; C M Elwood; F Knox
Journal:  J Nucl Med       Date:  1966-01       Impact factor: 10.057

9.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

10.  In vitro bactericidal effectiveness of four aminoglycoside antibiotics.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  1 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.